# Adaptive Biotechnologies Corp (ADPT) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Adaptive Biotechnologies Corp's 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/ADPT/mda/fy2025/): filed 2026-02-26; accession 0001193125-26-076902 (https://www.sec.gov/Archives/edgar/data/1478320/000119312526076902/adpt-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/ADPT/mda/fy2024/): filed 2025-03-03; accession 0000950170-25-030913 (https://www.sec.gov/Archives/edgar/data/1478320/000095017025030913/adpt-20241231.htm)
- [FY 2023 MD&A](/company/ADPT/mda/fy2023/): filed 2024-02-29; accession 0000950170-24-023095 (https://www.sec.gov/Archives/edgar/data/1478320/000095017024023095/adpt-20231231.htm)
- [FY 2022 MD&A](/company/ADPT/mda/fy2022/): filed 2023-02-14; accession 0000950170-23-002792 (https://www.sec.gov/Archives/edgar/data/1478320/000095017023002792/adpt-20221231.htm)
- [FY 2021 MD&A](/company/ADPT/mda/fy2021/): filed 2022-02-15; accession 0001564590-22-005228 (https://www.sec.gov/Archives/edgar/data/1478320/000156459022005228/adpt-10k_20211231.htm)

Back to /company/ADPT/